FDA.reportPublic FDA data

alcaftadine 0.25 % Ophthalmic Solution

RxCUI
1000085
RxNorm name
alcaftadine 0.25 % Ophthalmic Solution
Display name
alcaftadine 0.25 % Ophthalmic Solution
Full name
alcaftadine 0.25 % Ophthalmic Solution
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
alcaftadineALCAFTADINEAlembic Pharmaceuticals Inc.22473109-dc9e-45b6-b188-d7d5773f5a142024-10-07WarningsExact identifier
rxcui: 1000085
AlcaftadineALCAFTADINEGland Pharma Limitedb94e071d-421d-48ec-a4ea-254aa8af19ff2024-03-05WarningsExact identifier
rxcui: 1000085
AlcaftadineALCAFTADINEAurohealth LLCd550d462-ab7c-4703-9e6d-3b2360abac7d2023-06-23WarningsExact identifier
rxcui: 1000085
LASTACAFTALCAFTADINEAllergan, Inc.a3002410-4bf1-4182-9d7c-8193eb7cd2152022-08-10WarningsExact identifier
rxcui: 1000085
LASTACAFTALCAFTADINEAllergan, Inc.17d37e8d-7825-424b-b6ca-0a85d0bf46942020-06-01Warnings, Adverse reactionsExact identifier
rxcui: 1000085

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
17d37e8d-7825-424b-b6ca-0a85d0bf4694alcaftadine 0.25 % Ophthalmic SolutionSY21These highlights do not include all the information needed to use LASTACAFT ® safely and effectively. See full prescribing information for LASTACAFT ® . LASTACAFT ® (alcaftadine ophthalmic solution) , f or t opical o phthalmic u se Initial U.S. Approval: 201020200601
17d37e8d-7825-424b-b6ca-0a85d0bf4694alcaftadine 2.5 MG/ML Ophthalmic SolutionSCD21These highlights do not include all the information needed to use LASTACAFT ® safely and effectively. See full prescribing information for LASTACAFT ® . LASTACAFT ® (alcaftadine ophthalmic solution) , f or t opical o phthalmic u se Initial U.S. Approval: 201020200601
17d37e8d-7825-424b-b6ca-0a85d0bf4694alcaftadine 0.25 % Ophthalmic SolutionPSN21These highlights do not include all the information needed to use LASTACAFT ® safely and effectively. See full prescribing information for LASTACAFT ® . LASTACAFT ® (alcaftadine ophthalmic solution) , f or t opical o phthalmic u se Initial U.S. Approval: 201020200601
a3002410-4bf1-4182-9d7c-8193eb7cd215alcaftadine 0.25 % Ophthalmic SolutionSY4LASTACAFT ® Antihistamine Eye Drops Drug Facts20220810
a3002410-4bf1-4182-9d7c-8193eb7cd215alcaftadine 0.25 % Ophthalmic SolutionPSN4LASTACAFT ® Antihistamine Eye Drops Drug Facts20220810
a3002410-4bf1-4182-9d7c-8193eb7cd215alcaftadine 2.5 MG/ML Ophthalmic SolutionSCD4LASTACAFT ® Antihistamine Eye Drops Drug Facts20220810
22473109-dc9e-45b6-b188-d7d5773f5a14alcaftadine 2.5 MG/ML Ophthalmic SolutionSCD3.20241007
22473109-dc9e-45b6-b188-d7d5773f5a14alcaftadine 0.25 % Ophthalmic SolutionPSN3.20241007
22473109-dc9e-45b6-b188-d7d5773f5a14alcaftadine 0.25 % Ophthalmic SolutionSY3.20241007
b94e071d-421d-48ec-a4ea-254aa8af19ffalcaftadine 0.25 % Ophthalmic SolutionPSN3Alcaftadine Ophthalmic Solution 0.25%20240305
b94e071d-421d-48ec-a4ea-254aa8af19ffalcaftadine 0.25 % Ophthalmic SolutionSY3Alcaftadine Ophthalmic Solution 0.25%20240305
b94e071d-421d-48ec-a4ea-254aa8af19ffalcaftadine 2.5 MG/ML Ophthalmic SolutionSCD3Alcaftadine Ophthalmic Solution 0.25%20240305
d550d462-ab7c-4703-9e6d-3b2360abac7dalcaftadine 0.25 % Ophthalmic SolutionPSN120230623
d550d462-ab7c-4703-9e6d-3b2360abac7dalcaftadine 2.5 MG/ML Ophthalmic SolutionSCD120230623
d550d462-ab7c-4703-9e6d-3b2360abac7dalcaftadine 0.25 % Ophthalmic SolutionSY120230623
4b8c6afe-2d76-46c7-a23e-99db5e180ff6alcaftadine 0.25 % Ophthalmic SolutionSY1These highlights do not include all the information needed to use LASTACAFT ® safely and effectively. See full prescribing information for LASTACAFT ® . LASTACAFT ® (alcaftadine ophthalmic solution) 0.25% Initial U.S. Approval: 201020120905
4b8c6afe-2d76-46c7-a23e-99db5e180ff6alcaftadine 2.5 MG/ML Ophthalmic SolutionSCD1These highlights do not include all the information needed to use LASTACAFT ® safely and effectively. See full prescribing information for LASTACAFT ® . LASTACAFT ® (alcaftadine ophthalmic solution) 0.25% Initial U.S. Approval: 201020120905
4b8c6afe-2d76-46c7-a23e-99db5e180ff6alcaftadine 0.25 % Ophthalmic SolutionPSN1These highlights do not include all the information needed to use LASTACAFT ® safely and effectively. See full prescribing information for LASTACAFT ® . LASTACAFT ® (alcaftadine ophthalmic solution) 0.25% Initial U.S. Approval: 201020120905
c192fecc-046d-4905-868f-b8200320309calcaftadine 2.5 MG/ML Ophthalmic SolutionSCD1These highlights do not include all the information needed to use LASTACAFT™ safely and effectively. See full prescribing information for LASTACAFT™. LASTACAFT™ (alcaftadine ophthalmic solution) 0.25% Initial U.S. Approval: 201020100930
c192fecc-046d-4905-868f-b8200320309calcaftadine 0.25 % Ophthalmic SolutionPSN1These highlights do not include all the information needed to use LASTACAFT™ safely and effectively. See full prescribing information for LASTACAFT™. LASTACAFT™ (alcaftadine ophthalmic solution) 0.25% Initial U.S. Approval: 201020100930
c192fecc-046d-4905-868f-b8200320309calcaftadine 0.25 % Ophthalmic SolutionSY1These highlights do not include all the information needed to use LASTACAFT™ safely and effectively. See full prescribing information for LASTACAFT™. LASTACAFT™ (alcaftadine ophthalmic solution) 0.25% Initial U.S. Approval: 201020100930